Paradromics, Inc.

San Jose, CA · Founded 2015 · CIK 0001668302 · Medtech · Private

implantable neural recording device with massively parallel microwire electrode arrays bonded to custom CMOS readout electronics for brain-computer interfaces

paradromics.com →
Grants
$5.6M
5 awards
Sector median: 1
Raised
$55M
7 Form D · Apr 2023
42 months since last filing
Contracts
—
No federal contracts on record
Patents
24
7 granted · 17 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$985,000
Federal grantDepartment of Health and Human Services · Phase I · Commercial development of microwire bundle technology for massively parallel neural recording.$399,248
Federal grantDepartment of Health and Human Services · Phase I · Commercial development of microwire bundle technology for massively parallel neural recording.$398,523
Private capital raisedForm D · SEC$175,000
Private capital raisedForm D · SEC$6,193,530
Private capital raisedForm D · SEC$1,350,000
Private capital raisedForm D · SEC$4,102,479
Federal grantDepartment of Health and Human Services · Phase II · Development and evaluation of novel high-density intracortical microelectrode arrays for clinical applications$3,156,162
Federal grantDepartment of Health and Human Services · Phase II · Development and evaluation of novel high-density intracortical microelectrode arrays for clinical applications$1,433,024
Private capital raisedForm D · SEC$8,864,853
Private capital raisedForm D · SEC$33,012,815
Federal grantDepartment of Health and Human Services · Phase II · Development and evaluation of novel high-density intracortical microelectrode arrays for clinical applications$234,718
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1071METRIA INNOVATION, INC.——
1072Circulogene Theranostics, Inc.—$9.1M
1073Pepex Biomedical, Inc.—$202K
1074Paradromics, Inc.—$55M
1075ResQ Pharma, Inc.—$2.4M
1076ZSX MEDICAL LLC—$1.1M
1077Reflexion Pharmaceuticals, Inc.—$1.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 15 related persons
  • Matt AngleDirector · Executive Officer
  • Matthew AngleDirector · Executive Officer
  • Enke BashllariDirector
  • Enkelejda BashllariDirector
  • James BurrowsDirector · Executive Officer
  • Helmy EltoukhyDirector · Executive Officer
  • Edmund HuberDirector · Executive Officer
  • Zia HuqueDirector
  • Adam KablanianDirector
  • Ron KellyDirector
  • Yifan KongDirector
  • Thomas KrummelDirector
  • Amy KruseDirector
  • Dakin SlossDirector
  • Court WestcottDirector

Patents

USPTO · 7 granted of 24

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.